Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 596.85 INR 1.73%
Market Cap: 144.7B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Granules India Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Long-Term Investments
â‚ą215.2m
CAGR 3-Years
-12%
CAGR 5-Years
-11%
CAGR 10-Years
60%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Investments
â‚ą7.1B
CAGR 3-Years
-5%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Investments
â‚ą12.2B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
13%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Investments
â‚ą68.1B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
23%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Investments
â‚ą650m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Investments
â‚ą3.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Granules India Ltd
Glance View

Market Cap
144.7B INR
Industry
Pharmaceuticals

In the bustling corridors of the pharmaceutical world, Granules India Ltd. has carved out a distinctive niche through its unwavering commitment to efficiencies and economies of scale. Founded in 1984, the company began its journey as an operator of a small Paracetamol facility and steadily evolved into a formidable player on the global stage. Granules India's business model is streamlined; it meticulously integrates its manufacturing processes, focusing primarily on Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosage Forms (FDFs). By leveraging vertically integrated operations, the company ensures a seamless transition from raw material to finished product, reducing costs while maintaining high standards of product quality, an achievement that distinguishes it in the competitive landscape. Granules India capitalizes on its robust manufacturing infrastructure, which operates round the clock to serve a diverse clientele spanning across regulated and semi-regulated markets. This emphasis on cost-effective production is coupled with strategic geographical placement of its facilities, allowing it to cater efficiently to domestic and international markets, including North America, Europe, and emerging economies. The company's revenue streams are largely driven by the sales of its extensive product portfolio, which includes key therapeutic areas like over-the-counter (OTC) brands and prescription medications. By maintaining a diversified product line and emphasizing high-volume, low-margin products, Granules India continually fortifies its market position while sustaining a healthy balance between growth and stability.

GRANULES Intrinsic Value
456.52 INR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Granules India Ltd's Long-Term Investments?
Long-Term Investments
215.2m INR

Based on the financial report for Sep 30, 2024, Granules India Ltd's Long-Term Investments amounts to 215.2m INR.

What is Granules India Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
60%

Over the last year, the Long-Term Investments growth was -43%. The average annual Long-Term Investments growth rates for Granules India Ltd have been -12% over the past three years , -11% over the past five years , and 60% over the past ten years .

Back to Top